PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
1.43%
Growth of 1.43% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
1.93%
Cost growth exceeding 1.5x Healthcare median of 0.15%. Jim Chanos would check for structural cost disadvantages.
-0.51%
Gross profit decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
-1.92%
Margin decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-13.83%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-0.94%
Operating expenses reduction while Healthcare median is 5.04%. Seth Klarman would investigate advantages.
1.45%
Total costs growth below 50% of Healthcare median of 5.98%. Joel Greenblatt would investigate efficiency.
-6.25%
Interest expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
1.00%
D&A growth exceeding 1.5x Healthcare median of 0.63%. Jim Chanos would check for overinvestment.
-4.69%
EBITDA decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-6.04%
EBITDA margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
1.06%
Income change of 1.06% versus flat Healthcare. Walter Schloss would verify quality.
-0.37%
Operating margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
693.01%
Other expenses growth while Healthcare reduces costs. Peter Lynch would examine differences.
51.54%
Pre-tax income growth while Healthcare declines. Peter Lynch would examine advantages.
49.40%
Margin change of 49.40% versus flat Healthcare. Walter Schloss would verify quality.
49.60%
Tax expense change of 49.60% versus flat Healthcare. Walter Schloss would verify strategy.
52.44%
Income change of 52.44% versus flat Healthcare. Walter Schloss would verify quality.
50.28%
Margin change of 50.28% versus flat Healthcare. Walter Schloss would verify quality.
52.44%
EPS growth exceeding 1.5x Healthcare median of 3.88%. Joel Greenblatt would investigate advantages.
52.44%
Diluted EPS growth exceeding 1.5x Healthcare median of 4.00%. Joel Greenblatt would investigate advantages.
0.00%
Share count reduction exceeding 1.5x Healthcare median of 0.28%. Joel Greenblatt would investigate strategy.
0.00%
Diluted share reduction exceeding 1.5x Healthcare median of 0.27%. Joel Greenblatt would investigate strategy.